DPP-4 inhibitors

Introduction

Dipeptidyl Peptidase-4 Inhibitors (gliptans) are oral hypoglycemics that block DPP-4. This leads to an increase in the activity of incretins, which inhibit glucagon release, which in turn increase insulin secretion and slow gastric emptying, ultimately decreasing blood glucose levels.